Insider · CIK 0001623567

Happel David

Reports to the SEC for 3 companies · FOSTER CITY, CA

sec.gov

Transactions

Companies

Filings

CIK

0001623567

Forms 4 and 5

Insider transactions

26 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-07-20	SGMTSagimet Biosciences Inc.S Sale	Director, President & CEO	SSale	−64.1K sh	$7.76	−$497K	741,570
2026-05-28	SGMTSagimet Biosciences Inc. · Stock Option (Right to Buy)A Award	Director, President & CEO	AAward	+300K sh	—	—	300,000
2026-02-19	SGMTSagimet Biosciences Inc.A Award	Director, President & CEO	AAward	+128K sh	—	—	805,621
2026-02-19	SGMTSagimet Biosciences Inc. · Stock Option (Right to Buy)A Award	Director, President & CEO	AAward	+256K sh	—	—	256,000
2026-02-10	SGMTSagimet Biosciences Inc.S Sale	Director, President & CEO	SSale	−12.1K sh	$5.36	−$64.9K	677,621
2025-07-21	SGMTSagimet Biosciences Inc.S Sale	Director, President & CEO	SSale	−65.5K sh	$9.13	−$598K	689,722
2025-02-06	SGMTSagimet Biosciences Inc.A Award	Director, President & CEO	AAward	+116K sh	—	—	755,200
2025-02-06	SGMTSagimet Biosciences Inc. · Stock Option (Right to Buy)A Award	Director, President & CEO	AAward	+472K sh	—	—	472,000
2024-03-26	SGMTSagimet Biosciences Inc.P Purchase	Director, President & CEO	PPurchase	+12.1K sh	$5.27	+$63.7K	639,200
2023-12-07	SGMTSagimet Biosciences Inc.P Purchase	Director, President & CEO	PPurchase	+1,600 sh	$4.10	+$6,560	627,100
2023-11-17	SGMTSagimet Biosciences Inc.A Award	Director, President & CEO	AAward	+625K sh	—	—	625,500
2023-11-16	SGMTSagimet Biosciences Inc.P Purchase	Director, President & CEO	PPurchase	+590 sh	$2.35	+$1,386.5	590
2023-07-18	SGMTSagimet Biosciences Inc. · Stock Option (Right to Buy)D Disposition to Issuer	Director, President & CEO	DDisposition to Issuer	−1.01M sh	—	—	0
2023-07-18	SGMTSagimet Biosciences Inc. · Stock Option (Right to Buy)A Award	Director, President & CEO	AAward	+1.01M sh	—	—	1,011,826
2017-10-25	Horizon Therapeutics Public Ltd CoM Exercise/Conversion	EVP, Commercial Dev & Strategy	MExercise/Conversion	+7,953 sh	—	—	9,239
2017-10-25	Horizon Therapeutics Public Ltd CoF Tax Payment	EVP, Commercial Dev & Strategy	FTax Payment	−4,150 sh	$13.53	−$56.1K	5,089
2017-10-25	Horizon Therapeutics Public Ltd CoRestricted Stock UnitsM Exercise/Conversion	EVP, Commercial Dev & Strategy	MExercise/Conversion	−7,953 sh	—	—	23,860
2016-10-25	HORIZON PHARMACEUTICAL LLCD Disposition to Issuer	Chief Commercial Officer	DDisposition to Issuer	−28.9K sh	$9.00	−$260K	0
2016-10-25	HORIZON PHARMACEUTICAL LLCStock Option (right to buy)D Disposition to Issuer	Chief Commercial Officer	DDisposition to Issuer	−93.8K sh	—	—	0
2016-10-24	HORIZON PHARMACEUTICAL LLCU Disposition from Tender	Chief Commercial Officer	UDisposition from Tender	−8,934 sh	$9.00	−$80.4K	28,939
2016-03-01	HORIZON PHARMACEUTICAL LLCF Tax Payment	Chief Commercial Officer	FTax Payment	−576 sh	$3.43	−$1,977.408	29,670
2016-02-09	HORIZON PHARMACEUTICAL LLCA Award	Chief Commercial Officer	AAward	+25K sh	—	—	30,246
2016-02-09	HORIZON PHARMACEUTICAL LLCStock options (right to buy)A Award	Chief Commercial Officer	AAward	+93.8K sh	—	—	93,784
2015-02-09	HORIZON PHARMACEUTICAL LLCA Award	Chief Commercial Officer	AAward	+5,229 sh	—	—	5,229
2015-02-09	HORIZON PHARMACEUTICAL LLCStock options (right to buy)A Award	Chief Commercial Officer	AAward	+19.6K sh	—	—	19,583
2014-11-25	HORIZON PHARMACEUTICAL LLCStock options (right to buy)A Award	Chief Commercial Officer	AAward	+165K sh	—	—	165,000

Recent filings

Accepted (ET)
Jul 224
Happel David0001193125-26-312397
SEC(opens sec.gov)
Jun 14
Happel David0001104659-26-069121
SEC(opens sec.gov)
Feb 204
Happel David0001104659-26-018193
SEC(opens sec.gov)
Feb 124
Happel David0001104659-26-014283
SEC(opens sec.gov)
Jul 234
Happel David0001104659-25-070017
SEC(opens sec.gov)
Feb 74
Happel David0001104659-25-010587
SEC(opens sec.gov)
Mar 284
Happel David0001104659-24-040517
SEC(opens sec.gov)
Dec 84
Happel David0001104659-23-124678
SEC(opens sec.gov)
Nov 214
Happel David0001104659-23-120372
SEC(opens sec.gov)
Nov 204
Happel David0001104659-23-120027
SEC(opens sec.gov)
Jul 204
Happel David0001104659-23-082722
SEC(opens sec.gov)
Oct 264
Happel David0001209191-17-058085
SEC(opens sec.gov)
Oct 264
Raptor Pharmaceutical Corp0001140361-16-083653
SEC(opens sec.gov)

Companies

Address

SAGIMET BIOSCIENCES INC. 950 TOWER LANE, SUITE 1500

FOSTER CITY, CA, 94404